Try our Advanced Search for more refined results
Laurus Labs Pvt Ltd.
-
Misc | Filed: May 07, 2024 | Entered: May 07, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Proposed Order
PROPOSED ORDER re (1354 in 1:20-md-02930-RGA, 183 in 1:22-cv-01395-RGA) Letter by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard)
-
Discovery | Filed: May 07, 2024 | Entered: May 07, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of Novartis's Objections and Responses to Nanjing Noratech Pharmaceutical Co., Limited's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
-
Misc | Filed: May 06, 2024 | Entered: May 06, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Letter
Letter to The Honorable Richard G. Andrews from Richard C. Weinblatt regarding Discovery Dispute. (Weinblatt, Richard)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login